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Myelodysplastic Syndrome (MDS): 
• MDS is often called pre-leukemia as 1 in 3 individuals 
will develop Acute Myeloid Leukemia1
• A type of cancer that causes blood producing cells in 
bone marrow to function abnormally1
• Causes normal blood cells to die earlier 
Graft-Versus-Host-Disease (GVHD): 
• Develops in approximately 70% of patients following an 
allogenic stem cell transplant
• Donor’s cells attack both the malignancy and the 
patient’s healthy cells2
Corticosteroids:
• Treatment for acute and chronic GVHD (cGVHD) is often 
corticosteroids
• Can have detrimental effect on muscle strength, 
immune function, weight, and mood3
•In an allogenic 
stem cell 
transplant, a 
matched donor will 
donate the stem 
cells. 
Step 1: Cell 
Collection
•Patient undergoes 
high-dose 
chemotherapy to 
kill cancer cells and 
weaken immune 
system. 
Step 2: 
Treatment •The stored stem cells are introduced 
to the patient in 
hopes they will 
cause a graft-
versus-tumor-
effect. 
Step 3: 
Transfusion
•The paYent takes 
medicaYons to 
prevent adverse 
eﬀects, GVHD, and 
assist in recovery.  
Step 4: Recovery
Stem Cell Transplant: 
Purpose:
Background: 
Case Description:
• 73-year-old male admitted to MD Anderson Cancer 
Center with progressive weakness in bilateral lower 
extremities and loss of bowel/bladder function.
• Initial diagnosis as paraplegia with loss of 
bladder/bowel function and Brown Sequard Syndrome. 
• Diagnosis changed to paraplegia with unclear etiology
• Patient was a retired chemical engineer who enjoyed 
spending time with his family and tending to his yard.
• He lived in a 2-story home, bedroom/bathroom on the 
main level with no stairs to enter. 
Table 1: Tests & Measures
Tests & 
Measures IE  Results Progress Note Results 
Inpatient 
Rehab 
Discharge 
Light Touch 
Sensation WNL WNL WNL
Manual 
Muscle 
Testing
Decreased 
strength R > L 
Decreased 
strength R>L 
Decreased 
strength R >L 
5x Sit to 
Stand 
Unable to 
asses 16.3 seconds 
FIM Bed 
Mobility 5 (SBA) 5 (SBA) 
FIM Transfer 4 (CGA/Min 
Assistance) 6 (Mod-I) 5 (SBA) 
Ambulation 
Distance 2 ft
200 ft x1, 150 
ft x2 ft 800 ft x 2 
FIM 
Ambulation 
2 (Total 
Assist) 1 5 (SBA)
FIM Stairs 0 (Unable to 
assess/ 
perform)
0 0 
AM-PAC 
Basic 
Mobility
18 /24 20/24 20/24
WNL = within normal limits, R = right, L = left, SBA = stand by 
assistance, CGA = contact guard assist, FIM (Functional 
Independence Measure)
Discussion:
Outcomes:
• Potential implications for clinical practice include focus 
on strength and ADL function in oncology rehab. 
• Further research is required to understand and 
alleviate the common complications that result in 
decreased function and mortality such as GVHD and 
chronic corticosteroid use. 
• Physical therapists play a critical role in functional 
mobility for cancer survivors. 
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Timeline:
Progression of Interventions:
Seated Strength 
Exercises 
- Marches, long arc 
quads, ankle DF/PF, 
hip abduction with 
knee extension, hip 
adduction
Standing Strength 
Exercises
-Marches, heel 
raises, knee flexion, 
hip abduction, hip 
extension 
Functional 
Mobility
-Ambulation, 
transfers, mini 
squats, sit to stand  
Balance
- Narrow base of 
support, tandem 
stance, removing 
arm support, eyes 
open & closed, 
single leg stance 
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-6  Wks to IE
• BLE 
weakness 
& loss of 
bowel & 
bladder 
function
-3 Days to IE
• Patient 
admitted 
Day 1 
• PT Initial 
Evaluation
• Transfer to 
chair
• Seated 
exercises
Day 2-3
• First attempt 
at 
ambulation
• Introduced 
standing 
exercises 
Day 6 -8
• FIM scores 
improving
• Introduce 
balance 
exercises
Day 11 
• Progress 
note 
Day 13
• Discharge 
from stem 
cell ﬂoor 
to 
inpaYent 
rehab
Past Medical History: 73-year-old male diagnosed with MDS 6 
years prior to iniYal evaluaYon (IE). Allogenic stem cell 
transplant 2 years prior to IE with subsequent GVHD treated 
by long-term corYcosteroids 
Patient room at 
MD Anderson 
Cancer Center
MD Anderson Cancer 
Center Houston, TX 
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• The purpose of this case report is to describe PT 
interventions for an individual with a cancer diagnosis 
who received an allo-SCT and subsequently had long-
term complications associated with cGVHD, long-term 
corticosteroid use, and cancer survivorship. 
